300318 博晖创新
已收盘 05-10 15:00:00
资讯
新帖
简况
博晖创新(300318)5月8日主力资金净买入1337.62万元
证券之星 · 05-08
博晖创新(300318)5月8日主力资金净买入1337.62万元
博晖创新:公司将继续聚焦主业,落实既定战略,狠抓科学管理,不断提高盈利水平
证券之星 · 04-28
博晖创新:公司将继续聚焦主业,落实既定战略,狠抓科学管理,不断提高盈利水平
博晖创新最新公告:一季度净利润1986.36万元 同比增长283.90%
证券之星 · 04-26
博晖创新最新公告:一季度净利润1986.36万元 同比增长283.90%
博晖创新(300318.SZ)发布一季度业绩,净利润1986万元,同比增长283.90%
智通财经 · 04-26
博晖创新(300318.SZ)发布一季度业绩,净利润1986万元,同比增长283.90%
图解博晖创新年报:第四季度单季净利润同比增0.14%
证券之星 · 04-26
图解博晖创新年报:第四季度单季净利润同比增0.14%
博晖创新(300318.SZ)发预亏,预计2023年度净亏损1512万元–3023万元
智通财经网 · 01-30
博晖创新(300318.SZ)发预亏,预计2023年度净亏损1512万元–3023万元
博晖创新:顺利通过高新技术企业重新认定 将继续享受相关优惠政策
财华社 · 2023-11-30
博晖创新:顺利通过高新技术企业重新认定 将继续享受相关优惠政策
博晖创新(300318.SZ)通过高新技术企业认定
智通财经网 · 2023-11-30
博晖创新(300318.SZ)通过高新技术企业认定
加载更多
公司概况
公司名称:
北京博晖创新生物技术集团股份有限公司
所属行业:
专用设备制造业
上市日期:
2012-05-23
主营业务:
北京博晖创新生物技术集团股份有限公司的主营业务为检验检测及生物制品。公司检验检测业务产品由检验仪器及检测试剂两部分构成,客户群体涵盖了医疗机构及非医疗机构两类。公司面向医疗机构的产品,主要涉及体外诊断检测领域,包括人体微量元素检测及人乳头瘤病毒(HPV)检测等;公司面向非医疗机构提供检测设备,主要为小型质谱分析仪器及相关产品,主要用户为环保检测机构以及生物、化学等科研机构实验室等。
发行价格:
15.00
{"stockData":{"symbol":"300318","market":"SZ","secType":"STK","nameCN":"博晖创新","latestPrice":5.79,"timestamp":1715324595000,"preClose":5.66,"halted":0,"volume":23136038,"delay":0,"floatShares":799000000,"shares":817000000,"eps":-0.0126,"marketStatus":"已收盘","marketStatusCode":5,"change":0.13,"latestTime":"05-10 15:00:00","open":5.63,"high":6.06,"low":5.61,"amount":134000000,"amplitude":0.0795,"askPrice":5.8,"askSize":1444,"bidPrice":5.79,"bidSize":921,"shortable":0,"etf":0,"ttmEps":-0.0126,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715563800000},"adr":0,"adjPreClose":5.66,"symbolType":"stock","openAndCloseTimeList":[[1715304600000,1715311800000],[1715317200000,1715324400000]],"highLimit":6.23,"lowLimit":5.09,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":816900495,"pbRate":3.33,"roa":"--","roe":"1.44%","epsLYR":-0.0305,"committee":0.240362,"marketValue":4730000000,"floatMarketCap":4624000000,"peRate":-459.523809,"changeRate":0.023,"turnoverRate":0.029,"status":0},"requestUrl":"/m/hq/s/300318","defaultTab":"news","newsList":[{"id":"2433713689","title":"博晖创新(300318)5月8日主力资金净买入1337.62万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433713689","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2433713689?lang=zh_cn&edition=full","pubTime":"2024-05-08 15:19","pubTimestamp":1715152772,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月8日收盘,博晖创新报收于5.67元,上涨5.98%,换手率3.3%,成交量26.32万手,成交额1.47亿元。近5日资金流向一览见下表:该股主要指标及行业内排名如下:博晖创新2024年一季报显示,公司主营收入2.62亿元,同比上升3.6%;归母净利润1986.36万元,同比上升283.9%;扣非净利润1836.63万元,同比上升330.1%;负债率40.21%,财务费用626.94万元,毛利率49.55%。博晖创新主营业务:检验检测及生物制品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800021184.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430870250","title":"博晖创新:公司将继续聚焦主业,落实既定战略,狠抓科学管理,不断提高盈利水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2430870250","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430870250?lang=zh_cn&edition=full","pubTime":"2024-04-28 16:00","pubTimestamp":1714291259,"startTime":"0","endTime":"0","summary":"证券之星消息,博晖创新(300318)04月28日在投资者关系平台上答复投资者关心的问题。投资者:其它血制品企业净利润为30%左右,公司是不是故意隐藏利润,请问目的是什么?博晖创新董秘:尊敬的投资者,您好!公司将继续聚焦主业,落实既定战略,狠抓科学管理,不断提高盈利水平。感谢您的关注!以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800003384.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430273753","title":"博晖创新最新公告:一季度净利润1986.36万元 同比增长283.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430273753","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430273753?lang=zh_cn&edition=full","pubTime":"2024-04-26 19:50","pubTimestamp":1714132207,"startTime":"0","endTime":"0","summary":"博晖创新公布2024年第一季度报告,报告期营业收入2.62亿元,同比增长3.60%;归属于上市公司股东的净利润1986.36万元,同比增长283.90%;归属于上市公司股东的扣除非经常性损益的净利润1836.63万元,同比增长330.10%;基本每股收益0.0243元。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600049656.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430822859","title":"博晖创新(300318.SZ)发布一季度业绩,净利润1986万元,同比增长283.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430822859","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430822859?lang=zh_cn&edition=full","pubTime":"2024-04-26 17:20","pubTimestamp":1714123215,"startTime":"0","endTime":"0","summary":"智通财经APP讯,博晖创新(300318.SZ)发布2024年第一季度报告,报告期内实现营业收入2.62亿元,同比增长3.60%,实现归属于上市公司股东的净利润1986万元,同比增长283.90%,实现归属于上市公司股东的扣除非经常性损益的净利润1837万元,同比增长330.10%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1111665.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430341492","title":"图解博晖创新年报:第四季度单季净利润同比增0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430341492","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430341492?lang=zh_cn&edition=full","pubTime":"2024-04-26 01:03","pubTimestamp":1714064598,"startTime":"0","endTime":"0","summary":"证券之星消息,博晖创新2023年年报显示,公司主营收入10.45亿元,同比上升31.35%;归母净利润-2492.94万元,同比上升68.22%;扣非净利润-2765.77万元,同比上升71.1%;其中2023年第四季度,公司单季度主营收入2.39亿元,同比上升20.55%;单季度归母净利润-3906.66万元,同比上升0.14%;单季度扣非净利润-3977.2万元,同比上升28.03%;负债率40.38%,投资收益149.73万元,财务费用2584.31万元,毛利率43.51%。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600000961.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2407388067","title":"博晖创新(300318.SZ)发预亏,预计2023年度净亏损1512万元–3023万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2407388067","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2407388067?lang=zh_cn&edition=full","pubTime":"2024-01-30 16:06","pubTimestamp":1706601960,"startTime":"0","endTime":"0","summary":"博晖创新(300318.SZ)披露2023年度业绩预告,公司预计归属于上市公司股东的净亏损1512万元–3023万元,同比亏损收窄;扣除非经常性损益后的净亏损1836万元–3347万元。报告期,公司营业收入增长,毛利水平提高,经营业绩大幅改善。公司血液制品业务营收规模和毛利水平同比均有明显提升。公司体外诊断业务的营收规模和毛利水平同比也有一定提升。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-30/doc-inafhxve7182047.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-30/doc-inafhxve7182047.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2387419098","title":"博晖创新:顺利通过高新技术企业重新认定 将继续享受相关优惠政策","url":"https://stock-news.laohu8.com/highlight/detail?id=2387419098","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2387419098?lang=zh_cn&edition=full","pubTime":"2023-11-30 16:28","pubTimestamp":1701332900,"startTime":"0","endTime":"0","summary":"博晖创新(300318)公告称,公司于近日收到北京市科学技术委员会、北京市财政局、国家税务总局北京市税务局联合颁发的《高新技术企业证书》,公司再次顺利通过了高新技术企业认定。本次认定是公司原《高新技术企业证书》有效期满后的再次认定,根据有关规定,公司再次通过高新技术企业认定后,自颁发证书之日起连续三年继续享受相关优惠政策,按15%的税率征收企业所得税。","market":"us","thumbnail":"https://www.finet.hk/images/news_default.jpg","type":0,"news_type":0,"thumbnails":["https://www.finet.hk/images/news_default.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/6568488d53243c0783753f4b","is_publish_highlight":false,"gpt_icon":0},{"id":"2387132554","title":"博晖创新(300318.SZ)通过高新技术企业认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2387132554","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2387132554?lang=zh_cn&edition=full","pubTime":"2023-11-30 15:43","pubTimestamp":1701330180,"startTime":"0","endTime":"0","summary":"博晖创新(300318.SZ)发布公告,公司于近日收到北京市科学技术委员会、北京市财政局、国家税务总局北京市税务局联合颁发的《高新技术企业证书》,公司再次顺利通过了高新技术企业认定。据悉,本次认定是公司原《高新技术企业证书》有效期满后的再次认定,根据《中华人民共和国企业所得税法》和《高新技术企业认定管理办法》等有关规定,公司再次通过高新技术企业认定后,自颁发证书之日起连续三年继续享受国家关于高新技术企业的相关优惠政策,按15%的税率征收企业所得税。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-11-30/doc-imzwkrrt1418328.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-11-30/doc-imzwkrrt1418328.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2012-05-23","address":"北京市昌平区生命园路9号","stockEarnings":[{"period":"1week","weight":0.1113},{"period":"1month","weight":0.1697},{"period":"3month","weight":0.3688},{"period":"6month","weight":-0.0967},{"period":"1year","weight":0.0266},{"period":"ytd","weight":-0.0721}],"companyName":"北京博晖创新生物技术集团股份有限公司","boardCode":"AI0035","perCapita":"21120股","boardName":"专用设备制造业","registeredCapital":"81690万元","compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.042},{"period":"3month","weight":0.1007},{"period":"6month","weight":0.038},{"period":"1year","weight":-0.0468},{"period":"ytd","weight":0.0604}],"survey":" 北京博晖创新生物技术集团股份有限公司的主营业务为检验检测及生物制品。公司检验检测业务产品由检验仪器及检测试剂两部分构成,客户群体涵盖了医疗机构及非医疗机构两类。公司面向医疗机构的产品,主要涉及体外诊断检测领域,包括人体微量元素检测及人乳头瘤病毒(HPV)检测等;公司面向非医疗机构提供检测设备,主要为小型质谱分析仪器及相关产品,主要用户为环保检测机构以及生物、化学等科研机构实验室等。","serverTime":1715452839279,"listedPrice":15,"stockholders":"37809人(较上一季度增加7.68%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"博晖创新(300318)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供博晖创新(300318)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"博晖创新,300318,博晖创新股票,博晖创新股票老虎,博晖创新股票老虎国际,博晖创新行情,博晖创新股票行情,博晖创新股价,博晖创新股市,博晖创新股票价格,博晖创新股票交易,博晖创新股票购买,博晖创新股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"博晖创新(300318)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供博晖创新(300318)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}